GLOBUS MEDICAL INC - A (GMED)

US3795772082 - Common Stock

50.43  +0.64 (+1.29%)

After market: 50.43 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
958.1M
21.43%		1.023B
6.75%		1.568B
53.35%		2.514B
60.28%
EBITDA
YoY % growth
264.8M
48.51%		304.6M
15.03%		346.583M
13.78%		741.9M
114.06%
EBIT
YoY % growth
194.9M
68.89%		236.3M
21.24%		201.85M
-14.58%		480.85M
138.22%		N/A
Operating Margin
20.34%23.10%12.87%19.13%N/A
EPS
YoY % growth
2.04
42.66%		2.07
1.47%		2.33
12.56%		2.75
17.81%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		0.58
9.22%
Revenue
Q2Q % growth		598.88M
116.44%
EBITDA
Q2Q % growth		162.65M
EBIT
Q2Q % growth		99.797M
72.66%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 0.60
1.69%		0.62-0.02-3.57%
Q3 2023
Q2Q % growth		 0.57
14.00%		0.58-0.01-2.25%
Q2 2023
Q2Q % growth		 0.63
12.50%		0.610.024.09%
Q1 2023
Q2Q % growth		 0.53
26.19%		0.520.012.20%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 616.534M
124.60%		620.2M-3.666M-0.59%
Q3 2023
Q2Q % growth		 383.6M
50.96%		435.83M-52.23M-11.98%
Q2 2023
Q2Q % growth		 291.6M
10.62%		285.32M6.28M2.20%
Q1 2023
Q2Q % growth		 276.7M
20.04%		260.39M16.31M6.26%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0.35% -6.72% 0.02% -1.37%
Revenue0.17% -0.94% 0% -0.4%